-
Tweets194
-
Followers295
-
Following15
-
Likes37
Exciting results as we become the first company announcing positive topline results from a confirmatory patient study for a new biosimilar candidate in inflammatory disease. Marketing applications filed in major markets later this year. Read more: ow.ly/ogzN50Rn01L
Our second biosimilar has been approved by the FDA. A green light for the U.S. comes on the heels of approvals in other major global markets, Canada, Japan and Europe. Kudos to our partner, @TevaUSA. #healthcareaccess #biosimilars #biologics
Happy Easter from everyone at Alvotech. As we continue increasing access to affordable biologics, we look forward to sharing with you news of coming approvals, launches and filings. #biosimilars #biologics #healthcareaccess
Thanks to the many investors, partners, contractors and friends who joined us to celebrate 🎉 the opening of our Reykjavik facility extension last week, including the current and previous mayors of Reykjavik. #healthcareaccess #biotech #Reykjavik
Thanks to all who honored us by attending the Grand Opening for Alvotech's facility extension. Only 3 years passed since we broke ground and our staff has moved in. We are looking forward to telling you about R&D milestones and multiple global launches of our biosimilars.
We are pleased to announce FDA approval of the first high-concentration citrate-free interchangeable biosimilar adalimumab in the U.S. market. ow.ly/PIaB50QHSeA #healthcareaccess #biosimilars
We are happy to announce that market entry for our next biosimilar, AVT04 (ustekinumab) is expected in Canada in Q1, Japan in Q2 and Europe in Q3. Entry to the U.S. market will be in February 2025, pending FDA approval. ow.ly/gmx450QBUiT
Women represent half of the world’s population, but remain underrepresented in the STEM fields. Alvotech has achieved and strives to maintain gender balance. Diversity increases the pool of talent, fresh perspectives, and creativity. #womeninscience #equality #diversity #STEM
We are thrilled to receive European marketing authorization for our ustekinumab biosimilar, which @STADA will market in Europe. ow.ly/tSkP50QpwBZ #biosimilars #HealthAccess
Snow in Reykjavik 🎄 , the aroma of chocolate ☕ and Yule songs 🎅 filling the air. Today's winter solstice 🌄 heralds longer days. May your holidays be merry and bright.🙏
Meeting with investors at the Jefferies London Healthcare Conference. Our presentation will be streamed live today on our website at 1 pm GMT / 8 am ET. Register to view here: ow.ly/yc9K50Q7oq0 #JefferiesHealthcare #HealthAccess #biosimilars
Health Canada has granted JAMP Pharma marketing authorization for our ustekinumab biosimilar candidate, the first in Canada. #biosimilars #HealthcareAccess #BioJAMP Read all about it: ow.ly/onec50Q7o7W
The #CHMP has adopted a positive opinion for our AVT04 biosimilar candidate, the first for ustekinumab in Europe, an important step for patient access #biosimilars #HealthcareAccess #STADA Read all about it: ow.ly/xLWj50Q6suO
Alvotech will participate in the Jefferies London Healthcare Conference taking place in London on November 14-16, 2023. Our presentation is scheduled for Wednesday, November 15, 2023, at 1:00 pm GMT (8:00 am ET). To view the webcast go to: ow.ly/VLMp50Q4ZS4
Lilja Kjalarsdottir, Alvotech's Head of R&D Business Operation and Strategy, was a featured speaker at this year's Innovation Summit, held by the Intellectual Property Office. vimeo.com/875108005 #biotech #innovation #biosimilars
The Alvotech team has just landed in Barcelona, where CPhi 2023 - one of the most significant events in the industry - opens tomorrow. We look forward to seeing old friends and making new connections. Visit Booth FDF 2M50 and say hi! #CPhi2023 #pharma #biosimilars
Alvotech is proud to share that Philip A. Caramanica, Chief IP Counsel and Deputy General Counsel, has been recognized as one of the world's leading IP strategists in IAM Patent Strategy 300. Congratulations Phil!
The theme of this year's World Arthritis Day is 'Living with a rheumatic and musculoskeletal disease (RMD) at all stages of life. One of Alvotech's goals is to reduce healthcare costs for RMD patients. More at ow.ly/HRnL50PW15F. #ArthritisAwareness #HealthcareAccess
Nahla Hefferan @heffe_na
65 Followers 5K Following
Magnus Mar Kristinss @mar_magnus
3 Followers 31 Following
Emersyn Varnum @emers_varnu
70 Followers 5K Following
Elenore Yant @ElenoreYan88069
22 Followers 5K Following
Joleen Jackowiak @JackowJol
92 Followers 5K Following
Pauletta Hardgrove @PHardgro
39 Followers 5K Following
Sigurjón RafnRögnva.. @grjoniii
48 Followers 89 Following
Nordic Capital @davste86
374 Followers 1K Following Here for FinTwit. Currently PE Principal. Previously multi-strategy fund manager, M&A & restructuring.
Usha Bughani @UBughaniwork
1 Followers 50 Following
Serenity Espinoza @SerenityEs38670
52 Followers 3K Following
julie mueller @hawaii5656
8 Followers 62 Following
Chris Caramanica @chriscrr99
27 Followers 37 Following
Xiao @shawnapple87
0 Followers 15 Following
Herdís Harpa 🕊 @herdisharpa
77 Followers 917 Following
Ninbashi @NATSUPO1
163 Followers 654 Following この世はもっと自由で良いと思うシングルマザーのつぶやき。 主に黒いピットブルと大麻について語る。 肉は食べないけど、ヴィーガニズムは嫌い。
Guy Benson is a Liber.. @GuyBenson12
604 Followers 2K Following I’m Guy Benson and I’m a liberal. I pretend like I’m a conservative because I hate myself. I secretly have a crush on Anderson Cooper.
Weber Americano Jr @weberamericano
161 Followers 527 Following
William Thomas Mölle.. @WilliamWthm
386 Followers 585 Following MSc in organic chemistry 🧑🎓 Analytical development scientist 👨🏻🔬
Hörður Steinar @hordurs
80 Followers 492 Following
Chris Pitts @o5chriis
226 Followers 401 Following
John Sorbello @john_sorbello
23 Followers 106 Following
Eiríkur Bernharðsso.. @eirikur0119
33 Followers 131 Following
Karina Klenke @kari_klenk
45 Followers 5K Following
Eiliyah Sergio @EiliyahS56855
38 Followers 5K Following
김이박 @GimIbag86244
0 Followers 11 Following
Sasha Kellis @sas_kel
37 Followers 5K Following
Ívar Torfason @IvarTorfason
3 Followers 3 Following
Elissa Kaywork @eli20944
3 Followers 24 Following
Sumayyah Iwaoka @IwaoSumayya
48 Followers 5K Following
Louvenia Mathiew @MathiLouveni
44 Followers 5K Following
Cassondra Jergenson @CassondraJ71378
37 Followers 5K Following
Greta Almquist @GreAlmquis
30 Followers 5K Following
Bertha Orton @bertha_ort
43 Followers 5K Following
;( @petur_birgir
5 Followers 98 Following
J0SEPH SASHi (JOseph .. @josephsashi_O
220 Followers 5K Following Follow the instincts of your 🧡🤍💚💜🤎💛❤️🖤 and stick with the basics.
Punit Zadafiya @ZadafiyaPunit
3 Followers 21 Following
Satyendra Mishra @Satyendra8388
2 Followers 334 Following
Kristle Hambric @HambricKri65886
84 Followers 5K Following
C-CIT Sensors, a bran.. @CITSensMeMo
28 Followers 144 Following #Glucose and #Lactate in situ sensors for real time monitoring and #automation in #biomanufacturing #CellandGeneTherapy #CARTcells #CultivatedMeat
Luis de Torres @ShumakerJj
80 Followers 905 Following
Sandoz @Sandoz_Global
9K Followers 287 Following We are the #NewSandoz, the global leader in generic & biosimilar medicines. Our Purpose: #PioneeringAccess for patients.
U.S. FDA @US_FDA
563K Followers 145 Following Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0
EU Medicines Agency @EMA_News
118K Followers 354 Following Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.
Dr Bryony Mathew @BryonyMathew
7K Followers 3K Following 🇬🇧 British Ambassador to #Iceland 🇮🇸. Author of @AwesomeCareerBk. #diversity #inclusion #neuroscience #running @UKinIceland
Biosimilars Council @BiosimsCouncil
10K Followers 1K Following Biosimilars Council advocates for policies that support patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/73dlNwCdqQ…
AAM @AccessibleMeds
13K Followers 2K Following Association for Accessible Medicines promotes policies to ensure generic & biosimilar medicines are accessible to people who need them.
The Delta Group @TheDeltaGrp
366 Followers 179 Following PrintWeek 2022 Environmental Company of the Year Empowering Brands to Connect To Consumers.
JAMP Pharma Group @JampPharma
67 Followers 20 Following As a Canadian leader in product launches, we are present in all segments of the pharmaceutical market with a portfolio of over 325 molecules.
Csaba Bujna @BujnaCsaba
285 Followers 2K Following Founder of the Community "Berlin Tech Speed Networking" Digital Health | Future of AI | Clinical Technology | Career Development | Travel & Language Enthusiast
Amgen Biosimilars @AmgenBiosim
9K Followers 100 Following This account has joined @Amgen. Follow us there to learn more about biosimilars.
BioCGT🇵🇸 @AmirNLBio
120 Followers 579 Following 🇵🇸🇵🇸🇵🇸 | Bioprocessing | BioPharma industry | Cell & Gene therapies | biomanufacturing | 🇪🇺 🇳🇱 🇧🇪 🇩🇪
Róbert Wessman @RobertWessman
660 Followers 423 Following Chairman of Alvogen/ CEO & Founder of Alvotech/ Chairman of Lotus.
The theme of this year's World Arthritis Day is 'Living with a rheumatic and musculoskeletal disease (RMD) at all stages of life. One of Alvotech's goals is to reduce healthcare costs for RMD patients. More at ow.ly/HRnL50PW15F. #ArthritisAwareness #HealthcareAccess
To date, 40 #biosimilars have received @US_FDA approval, and 25 are available to #patients. With more than 90 new biosimilars currently in development, future savings and access to care will grow. Check out a full list of approved biosimilars here: bit.ly/3X6Myvy
[JUST RELEASED] New report shows that middlemen like health plans and pharmacy benefit managers (PBMs) increasingly block #patientaccess, delaying coverage of #newgenerics in favor of higher-priced brand drugs with high rebates. Read more: accessiblemeds.org/resources/pres…
🎉Congratulations to our friends and partners at @alvotechpr for making their debut on the Nasdaq Stock Market! We look forward to continuing our shared mission in expanding patient access to #biosimilars. @RobertWessman
Alvotech´s debut on the NASDAQ stock market on Thursday June 16 2022 offers investors direct exposure to global #biosimilars and marks the largest launch by an Icelandic company on a US stock exchange. #Alvo @NasdaqExchange alvotech.com/newsroom/alvot…
Þetta framtak hjá starfsfólki @alvotechpr og fyrirtækinu sjálfu hjálpar okkur mikið þar sem UNICEF og samstarfsaðilar vinna nú í kappi við tímann við að tryggja öryggi barna og fjölskyldna þeirra í Indlandi. Takk fyrir. 💙
#UNICEFThanks @alvotechpr @TeckResources for supporting the rollout of #Covid19vaccines in low- and low-middle income countries. No matter where you are, everyone should have an equitable opportunity to recover from the pandemic and rebuild lives and economies.
Stuðningur fyrirtækja skiptir UNICEF miklu máli líkt og stuðningur einstaklinga. Á dögunum gaf @alvotech okkur veglegan styrk til að setja í COVAX-samstarfið þar sem UNICEF gegnir lykilhlutverki í að koma bóluefnum til yfir 90 lág- og millitekjuríkja. 💙 Takk fyrir 💙
We are excited today to unveil our participation in an important initiative with @UNICEF. The Alvo companies are donating $100,000 towards UNICEF's struggle against the Coronavirus, read more: alvotech.com/newsroom/birna…
@SamsungBioepis Begins Ustekinumab Trial, @Cipla_Global Expands @alvotechpr Partnership, and CHMP Recommends @BioconBiologics and @ViatrisInc' Bevacizumab #Biosimilar $BIOCON $VTRS $PFE $MYL $CIPLA Read more: ow.ly/wLJj50DOm1p
Cipla Gulf expands partnership with Alvotech for marketing and distribution of four biosimilar medicines @Cipla_Global @alvotechpr bizzbuzz.news/markets/cipla-…
How do successful companies use Design of Experiments to drive innovation in R&D and production? Join us on February 11 to hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn. bit.ly/2M9r7KK #JMP #experiments #innovation #research #development
How do successful companies use design of experiments to drive innovation in R&D and production? On Feb. 11, you can hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn on how they use DOE bit.ly/3ovoDUs #JMP #experimentation #innovation
How do successful companies use Design of Experiments to drive innovation in R&D and production? Join us on February 11 to hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn. bit.ly/39OAoQA #JMP #experiments #innovation #research #development
How do successful companies use Design of Experiments to drive innovation in R&D and production? Join us on February 11 to hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn. bit.ly/3iyXDCf #JMP #experiments #innovation #research #development
How do successful companies use Design of Experiments to drive innovation in R&D and production? Join us on February 11 to hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn. bit.ly/3o4jjqM #JMP #experiments #innovation #research #development
Some of the prominent players include @ZydusUniverse @Sandoz_Global @SamsungBioepis @momentapharma @FreseniusKabi @EpirusBiopharma @Coherus_Bio @CinnaGen @bioxpress @bio_thera_sol @biogen @biocad_ltd @alvotechpr and @mAbxience. bit.ly/3qIBwfg
How do successful companies use Design of Experiments to drive innovation in R&D and production? Join us on February 11 to hear from industry experts from @Syngenta, Fuchs, @alvotechpr and @riffyn. bit.ly/3oaklC0 #JMP #experiments #innovation #research #development
Alvotech and Japanese pharmaceutical company Fuji Pharma have announced that they have agreed on an extension of their exclusive strategic partnership for the commercialization of four biosimilar medicines in Japan. Read more below! #teamalvotech alvotech.com/newsroom/alvot…
Joseph E. McClellan, PhD, MBA, discussed discussed how @alvotechpr navigates regulatory hurdles as the company continues its quest to line up distribution partnership deals across the globe. Read more: ow.ly/Xs0s50Cvl73
Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China @Alvotech_bio @alvotechpr pharmashots.com/52677/alvotech…
@alvotechpr Files for US and EU Approval of Adalimumab #Biosimilar Read more: ow.ly/Lu2750Cqqcv
Trends for United States
You might like
